Feng Xu, Beiping Li
Associate Professor, Department of Anaesthesiology, Xuzhou First People's Hospital, Xuzhou, Jiangsu, China.
Chief Physician, Department of Anaesthesiology, Xuzhou First People's Hospital, Xuzhou, Jiangsu, China.
J Clin Diagn Res. 2017 Sep;11(9):UC01-UC03. doi: 10.7860/JCDR/2017/26065.10533. Epub 2017 Sep 1.
Suffering from osteoarthritis is prevalent among elderly patients so the use of intra-articular injection of medical ozone may well be the effective way to relieve their pain.
To evaluate the effect of intra-articular injection of medical ozone given into the knee of the osteoarthritis patients, and to compare it with taking celecoxib and glucosamine orally.
In the present study, 76 patients suffering from osteoarthritis were randomly assigned into two groups. In the ozone group, 20 ml ozone-oxygen mixture gas concentration of 20 μg/ml was injected into knee articular cavity and each patient took oral celecoxib and glucosamine hydrochloride. Patients in control group only took the celecoxib and glucosamine hydrochloride orally.Pain score and Lysholm knee score were measured prior to the injection (pretreatment) and at one, three, six weeks after the beginning of the treatment (posttreatment).
After the treatment, the pain intensity and function significantly improved in the two groups compared with the pretreatment (p<0.05). In the ozone group, three weeks after intervention, the pain score improved significantly when compared with the control group (p<0.05).After the treatment, the lysholm scores increased significantly (p<0.05), but in the ozone group, it improved faster.
Intra-articular injection of ozone plus oral celecoxib and glucosamine could significantly decrease pain intensity in patients with mild to moderate Knee Osteoarthritis (KOA), and improve their functional status early than oral celecoxib and glucosamine only.
骨关节炎在老年患者中很常见,因此关节腔内注射医用臭氧很可能是缓解他们疼痛的有效方法。
评估关节腔内注射医用臭氧对骨关节炎患者膝关节的治疗效果,并与口服塞来昔布和氨基葡萄糖进行比较。
在本研究中,76例骨关节炎患者被随机分为两组。臭氧组将浓度为20μg/ml的20ml臭氧-氧气混合气体注入膝关节腔,每位患者口服塞来昔布和盐酸氨基葡萄糖。对照组患者仅口服塞来昔布和盐酸氨基葡萄糖。在注射前(预处理)以及治疗开始后的1周、3周、6周(治疗后)测量疼痛评分和Lysholm膝关节评分。
治疗后,两组的疼痛强度和功能与预处理相比均有显著改善(p<0.05)。在臭氧组中,干预3周后,与对照组相比疼痛评分有显著改善(p<0.05)。治疗后,Lysholm评分显著提高(p<0.05),但在臭氧组中改善更快。
关节腔内注射臭氧联合口服塞来昔布和氨基葡萄糖可显著降低轻至中度膝骨关节炎(KOA)患者的疼痛强度,并比单纯口服塞来昔布和氨基葡萄糖更早地改善其功能状态。